U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...
Truist downgraded Merck (MRK) to Hold from Buy with a price target of $110, down from $130, as part of a broader research note previewing FY25 ...
This was the stock's second consecutive day of gains.
By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Bearish flow noted in Merck (MRK) with 11,740 puts trading, or 3x expected. Most active are Feb-25 95 puts and Jan-25 100 calls, with total ...
The rising prevalence of diabetes is anticipated to drive the expansion of the semaglutide market in the coming years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback